Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
This study has been completed.
Study NCT00805805   Information provided by University of Michigan

First Received on December 8, 2008.   Last Updated on January 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Biliary Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
Liver Cirrhosis, Biliary
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Cholestasis
Cholestasis, Intrahepatic
Digestive System Diseases
Liver Diseases
Pathologic Processes
Interventions listed in this trial
Tetrathiomolybdate
Placebo
Additional drug interventions recognized in this trial
Molybdenum
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Chelating Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Sponsors listed in this trial
University of Michigan
FDA Office of Orphan Products Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services